(Stroke. 2000;31:1863.)
© 2000 American Heart Association, Inc.
Original Contributions |
Serial Measurement of Vascular Endothelial Growth Factor and Transforming Growth Factor-ß1 in Serum of Patients With Acute Ischemic Stroke
From the Department of Biological Sciences (M.S., P.K., J.G.), Manchester Metropolitan University, Manchester, UK, and the Department of Neuropathology (J.K., A. Slowik, A. Szczudlik), Jagiellonian University of Cracow, Poland.
Correspondence to M. Slevin, Department of Biological Sciences, Manchester Metropolitan University, Chester St, Manchester M1 5GD, UK. E-mail M.A.Slevin{at}mmu.ac.uk
Background and Purpose—Both vascular endothelial growth factor (VEGF) and transforming growth factor-ß1 (TGF-ß1) are expressed in higher than normal concentrations in the penumbra of patients after ischemic stroke. Because both cytokines are central to the processes of angiogenesis, tissue inflammation, and fibrosis, we performed serial measurements of these cytokines in patients with cerebral infarction and determined their relationship to stroke etiology and volume.
Methods—We serially (at days 0, 1, 3, 7, and 14) measured the serum levels of VEGF and active TGF-ß1 in 29 patients with acute ischemic stroke. Age-matched healthy subjects (n=26) were used as controls.
Results—Expression of VEGF was significantly increased in the majority of patients after acute stroke at each of the time points compared with normal controls. Highest expression occurred at day 7 (588±121 pg/mL; P=0.005), and it remained significantly elevated at 14 days after stroke. Expression of VEGF correlated with infarct volume, clinical disability (Scandinavian Stroke Scale), and peripheral leukocytosis and was significantly higher in patients with atherothrombotic large-vessel disease and ischemic heart disease (P<0.05 in all cases). In contrast, expression of active TGF-ß1 was not significantly different from control patients at any of the measured time points. When the mean concentration of TGF-ß1 from each patient (pooled time points) was compared with the control mean, a significant increase was found in only 2 patients, whereas levels decreased in 12 patients (P<0.05). There was no correlation between circulating active TGF-ß1 and VEGF expression, leukocytosis, stroke subtype, or patient disability as assessed by Scandinavian Stroke Scale score.
Conclusions—VEGF but not TGF-ß1 showed a dramatic increase in serum of stroke patients. Correlation between stroke severity and VEGF concentration suggests it could be involved in the subsequent repair processes resulting in partial recovery after stroke. Correlation between VEGF expression and peripheral leukocytosis suggests that these changes may also reflect the immunologic status of the patient. VEGF may play an important role in the pathophysiology of acute ischemic stroke and could be of value in future treatment strategies.
Key Words: angiogenesis • growth factors • stroke, acute • stroke, ischemic
This article has been cited by other articles:
 |
|
 |
|
  G. H. Kim, D. K. Hahn, C. P. Kellner, Z. L. Hickman, R. J. Komotar, R. M. Starke, W. J. Mack, J. Mocco, R. A. Solomon, and E. S. Connolly Jr Plasma Levels of Vascular Endothelial Growth Factor After Treatment for Cerebral Arteriovenous Malformations Stroke, August 1, 2008; 39(8): 2274 - 2279. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Thill, N. V. Strunnikova, M. J. Berna, N. Gordiyenko, K. Schmid, S. W. Cousins, D. J. S. Thompson, and K. G. Csaky Late Outgrowth Endothelial Progenitor Cells in Patients with Age-Related Macular Degeneration Invest. Ophthalmol. Vis. Sci., June 1, 2008; 49(6): 2696 - 2708. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Chopp, Z. G. Zhang, and Q. Jiang Neurogenesis, Angiogenesis, and MRI Indices of Functional Recovery From Stroke Stroke, February 1, 2007; 38(2): 827 - 831. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Al'Qteishat, J. Gaffney, J. Krupinski, F. Rubio, D. West, S. Kumar, P. Kumar, N. Mitsios, and M. Slevin Changes in hyaluronan production and metabolism following ischaemic stroke in man Brain, August 1, 2006; 129(8): 2158 - 2176. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. L. Lohr, D. C. Warltier, W. M. Chilian, and D. Weihrauch Haptoglobin expression and activity during coronary collateralization Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1389 - H1395. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Porcu, C. Emanueli, E. Desortes, G. M. Marongiu, F. Piredda, L. Chao, J. Chao, and P. Madeddu Circulating Tissue Kallikrein Levels Correlate With Severity of Carotid Atherosclerosis Arterioscler Thromb Vasc Biol, June 1, 2004; 24(6): 1104 - 1110. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Zhang, L. Wang, L. Zhang, J. Chen, Z. Zhu, Z. Zhang, and M. Chopp Nitric Oxide Enhances Angiogenesis via the Synthesis of Vascular Endothelial Growth Factor and cGMP After Stroke in the Rat Circ. Res., February 21, 2003; 92(3): 308 - 313. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Soderman, G. Rodesch, and P. Lasjaunias Transdural Blood Supply to Cerebral Arteriovenous Malformations Adjacent to the Dura Mater AJNR Am. J. Neuroradiol., September 1, 2002; 23(8): 1295 - 1300. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Lavie, H. Kraiczi, A. Hefetz, H. Ghandour, A. Perelman, J. Hedner, and P. Lavie Plasma Vascular Endothelial Growth Factor in Sleep Apnea Syndrome: Effects of Nasal Continuous Positive Air Pressure Treatment Am. J. Respir. Crit. Care Med., June 15, 2002; 165(12): 1624 - 1628. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Porcu, C. Emanueli, M. Kapatsoris, J. Chao, L. Chao, and P. Madeddu Reversal of Angiogenic Growth Factor Upregulation by Revascularization of Lower Limb Ischemia Circulation, January 1, 2002; 105(1): 67 - 72. [Abstract] [Full Text] [PDF]
|
|